BioLife Solutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLFS and other ETFs, options, and stocks.

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. 

CEO
Roderick de Greef
CEORoderick de Greef
Employees
155
Employees155
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
1987
Founded1987
Employees
155
Employees155

BLFS Key Statistics

Market cap
1.85B
Market cap1.85B
Price-Earnings ratio
36.01
Price-Earnings ratio36.01
Dividend yield
Dividend yield
Average volume
530.07K
Average volume530.07K
High today
$35.25
High today$35.25
Low today
$34.53
Low today$34.53
Open price
$35.12
Open price$35.12
Volume
348.53K
Volume348.53K
52 Week high
$35.35
52 Week high$35.35
52 Week low
$17.86
52 Week low$17.86

Stock Snapshot

BioLife Solutions(BLFS) stock is priced at $35.25, giving the company a market capitalization of 1.85B. It carries a P/E multiple of 36.01.

As of 2026-08-12, BioLife Solutions(BLFS) stock has fluctuated between $34.53 and $35.25. The current price stands at $35.25, placing the stock +2.1% above today's low and 0.0% off the high.

BioLife Solutions(BLFS) shares are trading with a volume of 348.53K, against a daily average of 530.07K.

During the past year, BioLife Solutions(BLFS) stock moved between $17.86 at its lowest and $35.35 at its peak.

During the past year, BioLife Solutions(BLFS) stock moved between $17.86 at its lowest and $35.35 at its peak.

BLFS News

Simply Wall St 3d
Why BioLife Solutions Is Up 7.8% After Swinging To Q2 Profitability And What's Next

In the second quarter of 2026, BioLife Solutions, Inc. reported sales of US$28.47 million, up from US$23.44 million a year earlier, and moved from a net loss of...

Why BioLife Solutions Is Up 7.8% After Swinging To Q2 Profitability And What's Next
TipRanks 6d
BioLife Solutions reports Q2 EPS 92c vs. 32c last year

Reports Q2 revenue $28.5M, consensus $28.17M. “We delivered another strong quarter, with solid execution across the business led by our market-leading biopreser...

Analyst ratings

89%

of 9 ratings
Buy
11.1%
Hold
88.9%
Sell
0%

People also own

Based on the portfolios of people who own BLFS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.